ID   MED4R
AC   CVCL_VU76
DR   Wikidata; Q95988368
RX   PubMed=24887326;
RX   PubMed=27498314;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU75 ! MED4
SX   Female
AG   7Y10M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=27498314; DOI=10.1016/j.jbiotec.2016.07.028;
RA   Ivanov, Delyan P.
RA   Coyle, Beth
RA   Walker, David A.
RA   Grabowska, Anna M.
RT   "In vitro models of medulloblastoma: choosing the right tool for the
RT   job.";
RL   J. Biotechnol. 236:10-25(2016).
//
RX   PubMed=24887326; DOI=10.1186/2051-5960-2-57; PMCID=PMC4229867;
RA   Othman, Ramadhan T.
RA   Kimishi, Ioanna
RA   Bradshaw, Tracey D.
RA   Storer, Lisa C.D.
RA   Korshunov, Andrey
RA   Pfister, Stefan Michael
RA   Grundy, Richard G.
RA   Kerr, Ian D.
RA   Coyle, Beth
RT   "Overcoming multiple drug resistance mechanisms in medulloblastoma.";
RL   Acta Neuropathol. Commun. 2:57.1-57.14(2014).
//